Liminatus Pharma, Inc. Class A Common Stock (LIMN) — Defensive Interval Ratio
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a Defensive Interval Ratio of 2223 days as of March 2025. Defensive assets of $6.46K (cash $-, short-term investments $-, receivables $6.46K) cover 2223 days of daily cash needs of $2.90/day. Check tangible equity quality of Liminatus Pharma, Inc. Class A Common St to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Liminatus Pharma, Inc. Class A Common Stock Defensive Interval Ratio (2021–2024)
This chart shows how Liminatus Pharma, Inc. Class A Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of March 2025, the ratio stands at 2223 days, meaning defensive assets of $6.46K can fund 2223 days of operations without new revenue. Also explore Liminatus Pharma, Inc. Class A Common St equity growth rate to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Liminatus Pharma, Inc. Class A Common Stock (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for Liminatus Pharma, Inc. Class A Common Stock from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is Liminatus Pharma, Inc. Class A Common St worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 0 days | $6.46K | $23.78K/day | $- | $- | ▼ -67 days |
| 2023 | 67 days | $945.00K | $14.13K/day | $- | $- | ▲ +57 days |
| 2022 | 10 days | $100.00K | $9.84K/day | $- | $- | ▲ +10 days |
| 2021 | 0 days | $1.26K | $3.78K/day | $- | $- | — |